Stem Cell Sciences Announces Grant of US Patent (STC.AX, 00748543, 20070815) Aspect Huntley via Yahoo!7 Finance Tue, 14 Aug 2007 3:55 PM PDT Stem Cell Sciences announced that the US Patent & Trademark Office has granted a broad patent covering SCS' Stem Cell Selection technology (US Patent 7,256,041). Claims granted to SCS by the USPTO cover all methods of purifying any type of mammalian stem cell via any introduced gene and all stem cells purified by the method. All adult human stem cells and all human embryonic stem cells are ... | Berk joins stem cell funding panel Rochester Business Journal Tue, 14 Aug 2007 12:38 PM PDT By JANICE BULLARD PIETERSE Rochester Business Journal August 14, 2007 University of Rochester Medical Center CEO Bradford Berk M.D. has been appointed to a state committee that will oversee distribution of $600 million in funding for stem cell research. | Encouraging signs in stem cell research St. Catharines Standard Tue, 14 Aug 2007 4:01 AM PDT Stem cell research holds the potential for so many medical breakthroughs, but has been hampered by serious ethical questions. The destruction of human embryos for cells that can be transformed into any in the body has proved as morally polarizing as it has medically exciting. | Team finds way to create cancer stem cells Addict 3D Tue, 14 Aug 2007 8:16 PM PDT MIT scientists and colleagues have found a way to create in the lab large amounts of cancer stem cells, or cells that can initiate tumors. The work, reported in the August 13 issue of Cancer Cell, could be a boon to researchers who study these elusive cells. | ProtoKinetix Targets Multi Billion Dollar Stem Cell Industry Business Wire via Yahoo! Finance Tue, 14 Aug 2007 4:00 AM PDT VANCOUVER, British Columbia----ProtoKinetix Inc. announced today that the Company has received from the University of Helsinki, a report confirming a major breakthrough in the storage of stem cells. | Team finds way to create cancer stem cells PhysOrg Tue, 14 Aug 2007 11:09 AM PDT MIT scientists and colleagues have found a way to create in the lab large amounts of cancer stem cells, or cells that can initiate tumors. The work, reported in the August 13 issue of Cancer Cell, could be a boon to researchers who study these elusive cells. Labs could easily grow them for use in experiments. | Invitrogen Launches Breakthrough Media For Human Embryonic Stem Cells BioresearchOnline Tue, 14 Aug 2007 7:20 AM PDT Invitrogen, a provider of essential life science technologies for research, production and diagnostics, and Novocell Inc., a stem cell engineering company, today announced the launch of a new fully-defined, serum- and feeder-free media specifically formulated for the growth and expansion of human embryonic stem cells (hESCs) | | |
|